237 related articles for article (PubMed ID: 15219287)
1. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
[TBL] [Abstract][Full Text] [Related]
2. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
[TBL] [Abstract][Full Text] [Related]
3. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery injection of Yttrium-90-lipiodol: biodistribution in rats with hepatoma.
Wang SJ; Lin WY; Lui WY; Chen MN; Tsai ZT; Ting G
J Nucl Med; 1996 Feb; 37(2):332-5. PubMed ID: 8667072
[TBL] [Abstract][Full Text] [Related]
5. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
Lee YS; Jeong JM; Kim YJ; Chang YS; Lee HJ; Son M; Lee JW; Yoon HS; Kang WJ; Lee DS; Chung JK; Lee MC; Suh YG
Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
[TBL] [Abstract][Full Text] [Related]
6. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
[TBL] [Abstract][Full Text] [Related]
8. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
[TBL] [Abstract][Full Text] [Related]
9. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
[TBL] [Abstract][Full Text] [Related]
10. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of lipiodol following hepatic arterial injection.
Hind RE; Loizidou M; Fleming J; Batty V; Birch S; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290
[TBL] [Abstract][Full Text] [Related]
12. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
Jeong JM; Kim YJ; Lee YS; Ko JI; Son M; Lee DS; Chung JK; Park JH; Lee MC
Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients].
Shi L; Zhang Z; Zhuang D; Cheng H; Gao Y; Wu M
Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):814-6. PubMed ID: 12487852
[TBL] [Abstract][Full Text] [Related]
14. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
Garin E; Noiret N; Malbert CH; Lepareur N; Roucoux A; Dazord L; Caulet-Maugendre S; Turlin B; Moisan A; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
[TBL] [Abstract][Full Text] [Related]
15. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
Liepe K; Kotzerke J; Lambert B
J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
[No Abstract] [Full Text] [Related]
16. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma.
Uccelli L; Pasquali M; Boschi A; Giganti M; Duatti A
Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276
[TBL] [Abstract][Full Text] [Related]
17. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours.
Wang SJ; Lin WY; Chen MN; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF
Eur J Nucl Med; 1996 Jan; 23(1):13-7. PubMed ID: 8586096
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
[TBL] [Abstract][Full Text] [Related]
20. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
Meléndez-Alafort L; Nadali A; Zangoni E; Banzato A; Rondina M; Rosato A; Mazzi U
Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
